Announcements Trials
Browse Landscape

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 4INDUSTRY 4

Study Type

Interventional 20Observational 4

Sponsor

Cancer Type

Breast 2Lymphoid 1Gastrointestinal 1

Conditions

Lymphoma, Follicular 1Dementia 1Colorectal Neoplasms 1Cognitive Dysfunction 1Breast Neoplasms 1Breast Cancer Female 1Alzheimer Disease 1

Interventions

Surveys and Questionnaires 529Blood Specimen Collection 406Surgical Procedures, Operative 152Radiotherapy 131Interviews as Topic 131Drug Therapy 123Observation 122Magnetic Resonance Spectroscopy 104Biopsy 103Specimen Handling 70Data Collection 70Neoadjuvant Therapy 65Immunohistochemistry 64Magnetic Resonance Imaging 61Immune Checkpoint Inhibitors 59Watchful Waiting 52Immunotherapy 51Bevacizumab 50Positron Emission Tomography Computed Tomography 46Ultrasonography 44Hematologic Tests 42Liquid Biopsy 41Tomography, X-Ray Computed 40Therapeutics 40Radiosurgery 40Colonoscopy 40pembrolizumab 37Hepatectomy 37Gene Expression Profiling 36High-Energy Shock Waves 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Observational × Drug Delivery Systems × Clear all
NCT05673759 2025-12-16

Event-Related Potential (ERP) Components in Clinical Diagnosis

Boston University

Terminated
148 enrolled
Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT04257799 2022-06-22

Lumpectomy Specimen Margin Evaluation With Tomography and Structured Light Imaging

Dartmouth-Hitchcock Medical Center

Completed
100 enrolled
Breast

Breast Cancer Female

NCT05349110 2022-05-05

COMET-OPTICAL

Maastricht University Medical Center

Unknown
105 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02690805 2021-04-19

Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System

University of California, Irvine

Completed
16 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡